ArticleCureus2025
A Rare Case of Hepatocellular Carcinoma With Osteoclast-Like Giant Cells: Favorable Outcome Following Early Surgical Resection.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatocellular carcinoma (HCC) containing osteoclast-like giant cells (OGCs) is an exceptionally rare histological variant, with few cases reported in the literature. These tumors typically exhibit aggressive behavior and a poor prognosis, often presenting at advanced stages. We report the case of a 71-year-old male with early-stage HCC harboring OGCs, incidentally detected during routine surveillance for prior colon cancer. Imaging findings were consistent with conventional HCC, and laparoscopic partial hepatectomy was performed. Histopathological examination revealed well-differentiated HCC with scattered OGCs. The patient recovered uneventfully and has remained recurrence-free for two years postoperatively, as confirmed by routine radiological surveillance. This case highlights the potential for favorable outcomes in HCC with OGCs when diagnosed and treated at an early stage. Further case accumulation is needed to better understand the clinical behavior and optimal management of this rare entity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.